John L. Zapas

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Edward H. Romond, Jong‐Hyeon Jeong, Priya Rastogi et al. · Journal of Clinical Oncology · 2012 · 514 citations · Full text

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Sandra M. Swain, Gong Tang, Charles E. Geyer et al. · Journal of Clinical Oncology · 2013 · 143 citations · Full text

The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma

Cynthia M. Simbulan‐Rosenthal, Sivanesan Dakshanamurthy, Anirudh Gaur et al. · Oncotarget · 2017 · 68 citations · Full text

Repurposed Anthelmintic Mebendazole, Pathology, Structure-based Drug Repositioning +18

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2

Patricia A. Ganz, Edward H. Romond, Reena S. Cecchini et al. · Journal of Clinical Oncology · 2017 · 68 citations · Full text

Ac Followed, Breast Oncology, Cancer Management +17